Once-Weekly Semaglutide in Adults with Overweight or Obesity

Curtis Williams presented the STEP-1 TRIAL, which is a randomized, placebo controlled clinical trial looking at this use of semaglutide in patients with elevated BMI and without diabetes. This trial was recently published in NEJM.